In this episode of the Huxley Morton Podcast, James is joined by Carlos Martin, the Chief Commercial Officer and Head of International at Rocket Pharma.

Carlos shares his journey from working in various roles at Novartis Oncology to embracing the entrepreneurial spirit at Rocket Pharma.

As CCO, he discusses the focus on developing gene therapies for treating rare pediatric conditions. Carlos emphasizes the importance of transitioning the company from a clinical-stage to a commercial-stage biotech firm while aligning with their mission to eradicate rare diseases using gene therapies.

He provides an insight into the challenges and strategies of creating, delivering, and commercializing complex therapeutics.